Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LDL receptor modulators are substances that influence the activity of the low-density lipoprotein receptor (LDLR), a cell surface glycoprotein primarily responsible for binding and internalizing cholesterol-rich low-density lipoproteins (LDL) from the bloodstream. The modulation of this receptor is central to maintaining cholesterol homeostasis and is a key therapeutic target in cardiovascular disease management.
Modulation of LDL receptor activity, influencing LDL uptake and clearance from the bloodstream. This can involve increasing receptor expression, preventing receptor degradation, or enhancing receptor binding affinity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Low-Density Lipoprotein Receptor Modulator.